Skip to main content
NHI logo

National Health Investors, Inc.

NHINYSEReal EstateREIT - Healthcare Facilities

$66.28Today:- (-)1Y −12.85%

As of Oct 16, 2026 close

Market cap
$3.18B
P/E (TTM)
19.10
Forward P/E
16.19
Dividend yield
5.63%
52-week range
$63.51$91.38
Volume (live)
-
Avg. volume (3M)
373.59K

National Health Investors (NHI) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), National Health Investors generated $240.23M of operating cash flow and spent $19.97M on capital expenditures. That left free cash flow of $220.26M, up 342.0% from $49.84M a year earlier, or 58.2% of revenue. It paid $169.70M in dividends.

National Health Investors Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for National Health Investors, Inc. (NHI) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income142.18136.64134.3865.50111.97185.13160.45154.33159.37
Depreciation & Amortization83.8574.3469.9778.4480.8083.1576.8275.7972.96
Deferred Income Tax0.000.000.000.00-29.040.000.825.85-7.87
Stock Based Compensation0.004.184.618.618.423.063.652.492.61
Change in Working Capital7.26-2.563.29-2.70-0.44-6.7418.70-0.57-2.46
Change in Accounts Payable5.493.295.930.433.350.000.304.591.61
Change in Other Working Capital1.77-1.90-2.64-3.53-3.79-6.7418.40-5.16-4.07
Other Operating Activities6.95-12.93-27.8035.3439.16-32.64-19.48-30.02-27.28
Net Cash from Operating Activities240.23207.77184.45185.34210.86232.15240.96207.87197.33
Investing Activities
Capital Expenditures-19.97-157.93-3.74-10.99-0.06-0.16-18.00-147.65-175.34
Acquisitions1.751.170.0011.74-187.54-0.880.640.000.00
Purchases of Investments-345.18-60.410.00-79.80-119.120.00-327.42-238.75-217.76
Sales/Maturities of Investments92.3319.450.00119.21306.650.002.904.3518.18
Other Investing Activities0.000.40-7.890.57185.34-88.68-0.64-102.65-6.69
Net Cash from Investing Activities-271.07-192.32-11.63197.95185.28-89.71-342.52-250.29-163.85
Financing Activities
Debt Repayment14.27-75.44-12.43-135.39-199.5554.27192.35268.87-61.74
Common Stock Issued181.53142.390.000.0047.9034.6595.7781.78122.24
Common Stock Repurchased0.00-5.820.00-152.240.00-2.710.000.000.00
Dividends Paid-169.70-156.51-156.24-161.77-182.90-194.58-179.74-165.39-153.04
Other Financing Activities-2.14-4.40-1.056.14-68.45-6.10-1.06-224.6357.49
Net Cash from Financing Activities23.96-13.57-169.72-401.25-402.99-111.76107.3244.26-35.05
Summary
Effect of Forex Changes on Cash2.210.060.000.000.000.000.000.000.00
Net Change in Cash-4.671.893.10-17.97-6.8630.675.761.84-1.57
Cash at Beginning of Period24.2922.3521.5239.4946.3415.679.918.084.64
Cash at End of Period19.6224.2924.6221.5239.4946.3415.679.913.06
Free Cash Flow220.2649.84180.71174.35210.80231.99222.9660.2221.98
Supplemental Disclosures
Interest Paid-55.3751.9042.6643.6843.41---
Income Taxes Paid-0.200.200.200.100.10---

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About National Health Investors Cash Flow

What is National Health Investors's free cash flow?

National Health Investors generated free cash flow of $220.26M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of $240.23M minus $19.97M of capital expenditures. That was up 342.0% from $49.84M a year earlier. Free cash flow equaled 58.2% of revenue.

How much does National Health Investors spend on capital expenditures?

National Health Investors spent $19.97M on capital expenditures in fiscal 2025, compared with $157.93M a year earlier. That equals 8.3% of operating cash flow.

Does National Health Investors pay dividends or buy back shares?

Yes. In fiscal 2025 National Health Investors returned $169.70M in dividends to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition